OTC Drug Monograph Reform Is on the HorizonByYin S. Chen, PharmD Candidate,Joseph L. Fink III, BSPharm, JD, DSC (Hon), FAPHANovember 5th 2019The success of PDUFA raises questions about additional funding to market nonprescription products.